A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study). Francisco Hernández-Bernal , Maria C Ricardo-Cobas , Yenima Martín-Bauta , Ernesto Rodríguez-Martínez , Klaudia Urrutia-Pérez , Karen Urrutia-Pérez , Joel Quintana-Guerra , Zadis Navarro-Rodríguez , Marjoris Piñera-Martínez , José L Rodríguez-Reinoso , Cristina O Chávez-Chong , Idania Baladrón-Castrillo , Grettel Melo-Suárez , Alejandro Batista-Izquierdo , Alexis Pupo-Micó , Ricardo Mora-Betancourt , Jacqueline Bizet-Almeida , Maria C Martínez-Rodríguez , Leonardo Lobaina-Lambert , Vivian M Velázquez-Pérez , Jalimy Soler-Díaz , Sandra Laurencio-Vallina , Tamara Meriño-Hechavarría , Norberto Carmenaty-Campos , Enri Rodríguez-Montero , Miladys Limonta-Fernández , Marel Alonso-Valdés , Reinier Hernández-Rodríguez , Eulogio Pimentel-Vázquez , Karem M Catasús-Álvarez , Maria V Cabrera-Núñez , Marta Ayala-Ávila , Verena L Muzio-González Social Science Research Network（2023）
摘要
Centre for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
更多 查看译文
关键词
spike, double-blind, placebo-controlled, sars-cov
AI 理解论文
溯源树
样例
